Literature DB >> 30635595

The use of less invasive surfactant administration (LISA) in the United States with review of the literature.

Dalibor Kurepa1, Shahana Perveen2, Yisrael Lipener2, Venkatakrishna Kakkilaya3.   

Abstract

BACKGROUND: The majority of extremely low gestational age neonates undergo intubation for surfactant therapy. Less invasive surfactant administration (LISA) uses a thin catheter inserted into the trachea to deliver the surfactant. During the procedure, the infant is breathing spontaneously while supported with continuous positive airway pressure. Although LISA is widely adapted in Europe and Australia, the rate of LISA use in the United States is unknown. STUDY
DESIGN: The aim of this study is to evaluate the use of LISA in the US. A web-based survey was distributed via SurveyMonkey to 2550 neonatologists from AAP's SoNPM mailing list.
RESULTS: Of the 472 neonatologists who answered the survey, 15% used LISA either as a part of routine care (8%) or as part of research (7%).
CONCLUSION: Unlike several regions of Europe, LISA is not widely used in the US. Future studies should address ambiguities regarding infant selection, procedure training and "roadblocks" to its broader application.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30635595     DOI: 10.1038/s41372-018-0302-9

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  9 in total

1.  Sedation for less invasive surfactant administration in preterm infants: a systematic review and meta-analysis.

Authors:  Laura Moschino; Viraraghavan Vadakkencherry Ramaswamy; Irwin Karl Marcel Reiss; Eugenio Baraldi; Charles Christoph Roehr; Sinno Henricus Paulus Simons
Journal:  Pediatr Res       Date:  2022-06-02       Impact factor: 3.756

2.  Influence of Genetic Information on Neonatologists' Decisions: A Psychological Experiment.

Authors:  Katharine Press Callahan; John Flibotte; Cara Skraban; Katherine Taylor Wild; Steven Joffe; David Munson; Chris Feudtner
Journal:  Pediatrics       Date:  2022-03-01       Impact factor: 7.124

Review 3.  Less invasive surfactant administration (LISA): chances and limitations.

Authors:  Egbert Herting; Christoph Härtel; Wolfgang Göpel
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2019-07-11       Impact factor: 5.747

4.  Quality assessment and response to less invasive surfactant administration (LISA) without sedation.

Authors:  Ellen de Kort; Suzanne Kusters; Hendrik Niemarkt; Carola van Pul; Irwin Reiss; Sinno Simons; Peter Andriessen
Journal:  Pediatr Res       Date:  2019-08-27       Impact factor: 3.756

5.  Multicentre, randomised trial of preterm infants receiving caffeine and less invasive surfactant administration compared with caffeine and early continuous positive airway pressure (CaLI trial): study protocol.

Authors:  Felix Ines; Shandee Hutson; Katherine Coughlin; Andrew Hopper; Anamika Banerji; Cherry Uy; Neil Finer; Wade Rich; Ana Morales; Jane Steen; Anup C Katheria
Journal:  BMJ Open       Date:  2021-01-22       Impact factor: 2.692

6.  A survey of minimally invasive surfactant therapy in Canada.

Authors:  Shaily Brahmbhatt; Brooke Read; Orlando Da Silva; Soume Bhattacharya
Journal:  Can J Respir Ther       Date:  2022-07-28

Review 7.  Should less invasive surfactant administration (LISA) become routine practice in US neonatal units?

Authors:  Venkatakrishna Kakkilaya; Kanekal Suresh Gautham
Journal:  Pediatr Res       Date:  2022-08-19       Impact factor: 3.953

8.  Study protocol for the POPART study-Prophylactic Oropharyngeal surfactant for Preterm infants: A Randomised Trial.

Authors:  Madeleine Claire Murphy; Marie Galligan; Brenda Molloy; Rabia Hussain; Peter Doran; Colm O'Donnell
Journal:  BMJ Open       Date:  2020-07-20       Impact factor: 2.692

9.  Alternative Methods of Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome: State of the Art.

Authors:  Ömer Erdeve; Emel Okulu; Kari D Roberts; Scott O Guthrie; Prem Fort; H Gözde Kanmaz Kutman; Peter A Dargaville
Journal:  Turk Arch Pediatr       Date:  2021-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.